Papers/PMID:33653154
Methylene blue for vasoplegic syndrome in cardiopulmonary bypass surgery: A systematic review and meta-analysis.
Asian cardiovascular & thoracic annals2021The record
2 findings drawn from this paper, on 1 compound across 2 endpoints, 2 of them null.
What it reported
How to read these marksEvery finding here is a null result.
What did not
2 findings
methylene blue — no detected effect on mean arterial pressure in vasodilatory shock
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull result“Pooled analysis revealed that mean arterial pressure, systemic vascular resistance, heart rate, and hospital stay were not statistically significant in methylene blue administration compared to control.”
Quoted verbatim from Methylene blue for vasoplegic syndrome in cardiopulmonary bypass surgery: A systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- adult patients with vasoplegic syndrome, methylene blue as adjunct treatment compared to control treatments
Methylene blue for vasoplegic syndrome in cardiopulmonary bypass surgery: A systematic review and meta-analysis.2021PMID:33653154
methylene blue — no detected effect on systemic vascular resistance
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull result“Pooled analysis revealed that mean arterial pressure, systemic vascular resistance, heart rate, and hospital stay were not statistically significant in methylene blue administration compared to control.”
Quoted verbatim from Methylene blue for vasoplegic syndrome in cardiopulmonary bypass surgery: A systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- adult patients with vasoplegic syndrome, methylene blue as adjunct treatment compared to control treatments
Methylene blue for vasoplegic syndrome in cardiopulmonary bypass surgery: A systematic review and meta-analysis.2021PMID:33653154